ArticleCase reports in dentistry2026
Photobiomodulation as an Alternative Approach for Bell's Palsy: Case Reports.
Article in Case reports in dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bell's palsy (BP), also known as idiopathic facial paralysis, is an idiopathic peripheral neuropathy that unilaterally affects the facial musculature. Its management includes various therapeutic modalities, among which photobiomodulation (PBM) has shown positive effects on neuromuscular regeneration. Objective: To describe the clinical outcomes of PBM in two patients with BP, one chronic and one acute. Methods: The first patient, a 58-year-old woman, presented with left-sided BP of 4 years' duration and had undergone multiple unsuccessful treatments. The second patient, a 15-year-old adolescent, was diagnosed 2 weeks prior to the initiation of PBM and underwent pharmacological therapy for 2 weeks, facial physiotherapy five times per week for 5 months, and auriculotherapy once weekly for 3 months. Both patients received infrared laser therapy (808 nm, 3 J/point) following individualized, progressive protocols. Results: In the chronic case, there was a significant reduction in orofacial pain from the first session and gradual improvement in facial mobility up to the fifteenth session, with follow-up extending to 18 months. Although complete facial symmetry was not restored, the patient reported enhanced self-confidence and quality of life. In the acute case, complete pain relief was achieved within a few sessions, and full functional recovery was observed after 14 sessions, with restoration of facial symmetry and emotional well-being. Clinical outcomes remained stable at the three-year follow-up. Conclusions: PBM proved to be an effective tool for managing both chronic and acute BP, promoting analgesia, motor recovery, and general well-being. Its integration into multidisciplinary treatment protocols may optimize therapeutic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.